Treatment of autonomic nerve dysfunction with botulinum toxin

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242361, 424 45, 424434, 424 7802, 514937, 514944, 514826, A61K 3574

Patent

active

057666059

ABSTRACT:
There is disclosed according to the present invention a method for the control of autonomic nerve function in a mammal comprising administering a therapeutically effective amount of botulinum toxin to the mammal. Preferred embodiments include administering the toxin to control the function of an autonomic nerve which contributes to at least one symptom of rhinorrhea, otitis media, excessive salivation, asthma, COPD, excessive stomach acid secretion, spastic colitis or excessive sweating.

REFERENCES:
Vita, G. et al. (1987). Arch. Neurol. 44:202-206.
Molgo, J. et al. (1990). J. Physiol. Paris 84:152-166.
Girlanda, P. et al. (1992). J. Neurol. Neurosurg. Psychiatry 55:844-845.
Ambache (1951). J. Physiology 113: 1-17.
Pasricha PJ, Ravich WJ, Hendrix TR, Sostre, S, Jones B, Kalloo AN. Intrasncteric Botulinum Toxin For The Treatment of Achalasia. N. Engl. J. Med. 1995;332:774-778.
Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of Achalasia with Intrasphincetric Injection of Botulinum Toxin. Ann. Intern. Med. 1994;121:590-591.
Pasricha PJ, Ravich WJ, Kalloo AN. Effects of Intrasphincetric Botulinum Toxin on the Lower Esophageal Sphincter in Piglets. Gastroenterology 1993;105:1045-1049.
Ferrari AP, Siqueira ES, Brant CQ. Treatment of Achalasia in Chaga's Diesease With Botulinum Toxin. N. Engl. J. Med. 1995;332:824-825.
Bushara KO, Park DM. Botulinum Toixn and Sweating. J. Neurol. Neurosurg. Psychtr. 1994;57(11):1437-1438.
Schantz EJ, Johnson EA. Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in medicine. Microbiological Reviews. 1992;56:80-99.
Gargarosa EJ. Botulism. In PD Hoeprich, ed., Infectious Diseases, Harper and Row, Hagerstown, Md., 1972.
Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. NEJM. 1991;324:1186-1194.
Malcomson KG. The vasomotor activities of the nasal mucous membrane. J Lar Otol 1959;73:73-98.
Krajina Z. Critical review of Vidian neurectomy. Rhinology 1989;27:271-276.
Eccles R, Wilson H. The parasympathetic secretory nerves of the nose of the cat. J. Physiol 1973;230:213-223.
Laurikainen E, Koulu M, Kaila T, Scheinin M, Isalo E. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide. Rhinology 1988;26:133-138.
Mygind N, Borum P. Effect of a cholino-ceptor antagonist in the nose. Eur J Respir Dis 1983;64 (suppl 128):167-174.
Golding-Wood PH. Pathology and surgery of the chronic vasomotor rhinitis. J Lar Otol 1962:76;969-977.
Malm L. Stimulation of sympathetic nerve fibres to the nose in cats. Acta Otolaryngol 1973;75:519-526.
Uddman R, Alumets J, Densert O, Hakanson R, Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol 1978;86:443-448.
Scott AB, Kennedy RA, Stubbs MA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Opthalmol 1985;103:347-350.
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthal Soc. 1981;79:734-770.
Black JD, Dolly JO. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience. 1987;23:767-779.
Ambache N. The peripheral action of Cl. botulinum toxin. J Physiol. 1949;108:127-141.
Carpenter FG. Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats. J Physiol. 1967;188:1-11.
Marier SH, Putney JW, Van de Walle CM. Control of calcium channels by membrane receptors in the rat parotid gland. J. Physiol. 1978;279:141-151.
Aub DL, McKinney JS, Putney JW. Nature of the receptor-regulated calcium pool in the rat parotid gland. J. Physiol. 1982;331:557-565.
Ekstrom J, Tobin G. Secretion of protein from salivary glands in the ferret in response to vasoactive intestinal peptide. J. Physiol. 1989;415:131-141.
Putney JW. Identification of cellular activation mechanisms associated with salivary secretion. Ann. Rev. Physiol. 1986;48:75-88.
Nakahari T, Miyamoto M, Yoshida H. Tanaka H, Imai Y. Continuous Measurements of Tissue Impedance during Secretion in Dog Submandibular Gland. Jpn J Physiol. 1988;38:699-712.
Dohi T, Yamaki H, Morita K, Kitayama S, Tsuru H, Tsujimoto A. Calcium dependency of adrenergic and muscarinic cholinergic stimulation of mucin release from dog submandibular gland cells. Archs Oral Biol. 1991;36:443-449.
Krajina Z, Harvey JE, Ogura JH. Experimental vasomotor rhinitis. Laryngoscope 1972;82:1068-1073.
Millonig AF, Harris HE, Gardner WJ. Effect of autonomic denervation on nasal mucosa. Arch Otolaryngol 1949;86:359-368.
Martling CR, Anggard A, Lundberg JM. Non-cholinergic vasodilation in the tracheobronchial tree of the cat induced by vagal nerve stimulation. Acta Physiol Scand 1985;125:343-346.
Anggard A. The effects of parasympathetic nerve stimulation on the microcirculation and secretion in the nasal mucosa of the cat. Acta Otolaryngol 1974;78:98-105.
Cauna N. Blood and nerve supply of the nasal lining. In: Proctor DF, Andersen I, eds. The nose. Upper airway physiology and the atmospheric environment. Amsterdam. Elsevier Biomedical Press, 1982;45-69.
Tos M. Distribution of mucus producing elements in the respiratory tract. Differences between upper and lower airway. Eur J Respir Dis 1983 (suppl 128):269-279.
Krajina M, and Poljak Z. Reaction of Nasal Mucosa in Rabbits after Cervical Sympathectomy. Acta oto-laryng.53, pp. 116-121.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of autonomic nerve dysfunction with botulinum toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of autonomic nerve dysfunction with botulinum toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of autonomic nerve dysfunction with botulinum toxin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1722042

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.